Immuno-Biological Laboratories Co.,Ltd.
Loading...
Key Metrics
Market Cap
N/A
P/E Ratio
N/A
P/B Ratio
N/A
Revenue
969.5M
Net Income
249.0M
Gross Margin
N/A
Op. Margin
21.6%
Net Margin
25.7%
ROE
16.4%
ROA
13.5%
D/E
0.22
Dividend Yield
N/A
EPS
26.74
Current Ratio
4.94
Price History
Company Info
| Industry | PHARMACEUTICAL |
| Market Segment | Growth |
| Accounting | Japan GAAP |
| Currency | JPY |
| Fiscal Year | 2025 |
Peers
GNI Group Ltd.
2160
--
P/E: --
Kyowa Kirin Co.,Ltd.
4151
--
P/E: --
--
P/E: --
Astellas Pharma Inc.
4503
--
P/E: --
--
P/E: --
Shionogi & Co.,Ltd.
4507
--
P/E: --
--
P/E: --
--
P/E: --
Financial Statements
Loading financials...
Open Advanced Charts
Full charting with technical indicators, candlestick, and more.
| Ticker | 4570 |
| Exchange | TSE |
| Sector | Pharmaceutical |
| Industry | PHARMACEUTICAL |